Growing prevalence of retinal diseases across the globe and rising number of strategic initiatives are expected to boost the growth of the global retina health market at a CAGR of 7.01% during the forecast period 2022 to 2030.

Market Research Future (MRFR) has published a cooked research report on the “Global Retina Health Market” that contains the information from 2022 to 2030.

Retina Health Market Highlights

The global retina health market is expected to register a CAGR of 7.01% during the forecast period and is expected to hit USD 24.22 million by 2030.

Retina refers to the thin layer present at the back of the eye which is responsible for the conversion of the light that enters the eye into electrical signals that can be processed into images by the brain. A healthy retina is essential for the prevention of vision impairments and even blindness. Macular degeneration and diabetic retinopathy are two common major retinal disorders affecting millions across the globe.

The growing prevalence of retinal diseases is attributed to improve retinal health's capabilities, providing new value-added medications and the rising number of strategic initiatives. However, lack of awareness regarding retinal diseases might retard the market's growth in the forecast period.

Key Players

MRFR recognizes the following companies as the key players in the global retina health market— Novartis AG (Switzerland), Spark Therapeutics, Inc. (Us), Gensight Biologics (France), Allergan Plc (Subsidiary of AbbVie Inc.) (Ireland), Oxford Biomedica Plc (UK), Hemera Biosciences LLC (US), Santen Pharmaceuticals Inc. (Japan), Regenxbio Inc. (US), Meiragtx Limited (US), Applied Genetic Technologies Corporation (AGTC) (US).

Segment Analysis

The global retina health market has been divided based on treatment and disease indication.

The market, based on treatment, has been segregated into drugs, therapy, and surgery. Therapy further segmented into gene therapy and nutrition therapy.

Based on disease indication, the retina health market has been divided into age-related macular degeneration, diabetic retinopathy, inherited retinal diseases, retinoblastoma, and others.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Retina Health Market Research Report

Regional Analysis

The global retina health market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. The North America market is further divided into the US and Canada. The Europe retina health market has been segmented into Germany, France, the UK, Italy, Spain, and the rest of Europe. The retina health market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World further segmented into Middle East, Africa, and Latin America.

The North America is expected to dominate retina health market due to high prevalence of retinal disorders, the presence of major market players in the region and the presence of many biopharmaceutical players in the region. Several eye care initiatives such as The Lions Eye Health Program among others are increasing public awareness about eye health and preventive measures to minimize the vision loss. Such aforementioned factors are anticipated to propel the growth of the market in this region.

Europe held a significant share in the global retina health market. High prevalence of wet AMD, increasing prevalence of diabetes, and presence of a high population of geriatric people leading to regional market expansion in Europe.

Asia-Pacific is expected to be the fastest-growing market in retina health, mainly due to the rapidly improving healthcare infrastructure, increasing per capita income, growing awareness about eye health among the population, and presence of a large geriatric population further boosting the market in the Asia-Pacific region.

The retina health market in Middle East & Africa is growing dramatically due to the growing investment in R&D activities across developing economies such as Kuwait, Qatar, Saudi Arabia, and Dubai. Moreover, the factors limiting the market growth of MEA region includes sub-par healthcare infrastructure, lack of qualified professionals, and limited public awareness among others.

Key Findings of the Study

• The global retina health market is expected to reach USD 24,220.77 million by 2030 at a CAGR of 7.01% during the forecast period.


• The North America region accounted for the largest share of the global market, owing to the to high prevalence of retinal disorders and the presence of major market players in the region.


• Based on treatment, the drugs segment is expected to register the fastest growth at a CAGR of 8.83% during the forecast period.


• Based on disease indication, the age-related macular degeneration segment held the largest market in 2021, with USD 9,576.19 million during the forecast period.


• Some of the key players operating in the retinal health market are Novartis AG (Switzerland), Spark Therapeutics, Inc. (Us), Gensight Biologics (France), Allergan Plc (Subsidiary of AbbVie Inc.) (Ireland), Oxford Biomedica Plc (UK).